Suzhou, CN Breaking News Headlines Today

News about Suzhou, China

Stay current with all the latest and breaking news about Suzhou, China, compare headlines and perspectives between news sources on stories happening today. In total, 60 stories have been published about Suzhou, China which Ground News has aggregated in the past 3 months.

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Suzhou, China News

Suzhou, China · Suzhou

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

80% Center coverage: 25 sources

SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other…See the Story

Suzhou, China · Suzhou

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

59% Center coverage: 22 sources

SUZHOU, China, Dec. 3, 2025 /PRNewswire/ -- On December 3, 2025 (local time in Arizona, USA), ImmVira Group ("ImmVira" or the "Company") announced a poster presentation at the 26th Annual Meeting of the Society of Urologic Oncology (SUO 2025). The…See the Story

$ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma$

Suzhou, China · Suzhou

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

88% Center coverage: 18 sources

SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major…See the Story

Suzhou Tianyuan Boosts Costing Accuracy to 98% with Coats Digital’s GSDCost

SUZHOU, CHINA and LONDON, UK – 17 December 2025 – Coats Digital is delighted to announce that Suzhou Tianyuan Garments Co., Ltd., a leading manufacturer of high-quality sportswear and functional apparel for global brands such as Adidas, FILA, ANTA, and The North Face, has achieved remarkable productivity and cost management improvements following the implementation of Coats Digital’s award-winning method-time-cost optimisation solution, GSDCost.…Adidas · Suzhou Read Article

Kunqu Opera Inspires SoBA's Fluid Suzhou Sports Park Design

The newly opened Vibrant Sports Park in Kunshan, Suzhou, represents a sophisticated fusion of deep Chinese cultural heritage… The post Soba Wraps Its Inclusive Sports Park in Suzhou With a Striking White Concrete Ribbon appeared first on urdesignmag.Suzhou, China · Suzhou Read Article

Suzhou Industrial Park visit inspires S’wak’s push toward advanced, sustainable industrial ecosystem

By DayakDaily Team KUCHING, Dec 12: The visit by Sarawak Premier Datuk Patinggi Tan Sri Abang Johari Tun Openg and his delegation to the Suzhou Industrial Park (SIP) Exhibition Centre in China today marked a new chapter in understanding how disciplined planning, effective governance, and technological innovation can shape a world-class industrial ecosystem. According to a report from the Sarawak Public Communication Unit (Ukas), the delegation w…Suzhou, China · Suzhou Read Article

GCL SI Joins COP30 Efforts to Standardize Global Carbon Credits

100% Right coverage: 1 sources

SUZHOU, China, Dec. 12, 2025 /PRNewswire/ -- As global attention turns to carbon credit standardization and traceability, in light of the recent COP30 climate conference held in...Belém · Belém See the Story

Professor Youmin Xi awarded University of Liverpool Fellowship

SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- Professor Youmin Xi, Executive President of Xi'an Jiaotong-Liverpool University (XJTLU), has received an Honorary Fellowship from the University of Liverpool. The award recognises his success in leading XJTLU – an innovative partnership between the University of Liverpool in the UK and Xi'an Jiaotong University in China – and his significant contributions to improving global higher education. The hono…Suzhou, China · Suzhou Read Article

Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond

100% Right coverage: 1 sources

SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein...Suzhou, China · Suzhou See the Story

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

88% Center coverage: 18 sources

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

80% Center coverage: 25 sources

Daniel Ramos Lost the Last of China's taça for Beijing Guan

The meeting held in Suzhou was decided with a 'hat-trick' of the old advanced Marítimo, Penafiel and Moreirense, which marked the 16th 45+7 and 90+2 minutes, the last two of great penalties. Guga, the average Portuguese who passed by Benfia, Famalicão and Rio Ave, was titled in Beijing Guoan, who won China's Taça for the fifth time. Also read: EM DIRETO: Arsenal has lost and City is already in action... from topLisbon, Portugal · Lisbon See the Story

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

59% Center coverage: 22 sources

News about Suzhou, China

News about Suzhou, China

Local News Publishers Too Big Arrow Icon

Top Suzhou, China News

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

Suzhou Tianyuan Boosts Costing Accuracy to 98% with Coats Digital’s GSDCost

Kunqu Opera Inspires SoBA's Fluid Suzhou Sports Park Design

Suzhou Industrial Park visit inspires S’wak’s push toward advanced, sustainable industrial ecosystem

GCL SI Joins COP30 Efforts to Standardize Global Carbon Credits

Professor Youmin Xi awarded University of Liverpool Fellowship

Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

Daniel Ramos Lost the Last of China's taça for Beijing Guan

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

Local News Publishers Too Big Arrow Icon

Suzhou Tianyuan Boosts Costing Accuracy to 98% with Coats Digital’s GSDCost

Kunqu Opera Inspires SoBA's Fluid Suzhou Sports Park Design

Suzhou Industrial Park visit inspires S’wak’s push toward advanced, sustainable industrial ecosystem

GCL SI Joins COP30 Efforts to Standardize Global Carbon Credits

Professor Youmin Xi awarded University of Liverpool Fellowship

Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

Daniel Ramos Lost the Last of China's taça for Beijing Guan

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

Local News Publishers

Local News Publishers